Work in progressFolivue is still being built, so expect rough edges. Found a bug? Report it on the roadmap. Enjoying it? Buy me a coffee.Expect rough edges. Found a bug? Report it. Folivue is free. Want to help? Buy me a coffee.

Market snapshot

USEuropeAsiaLatin AmericaCurrenciesCryptoFutures

Dow Jones----S&P 500----Nasdaq----Russell----VIX----

Home›

Compare to

In the news

Keep browsing

You may be interested in

Help Roadmap & feedback Support Folivue Privacy Terms Disclaimer

ToolsStock return calculator Export Google Finance portfolios and watchlist to CSV

GuidesGoogle Finance classic view, rebuilt The new Google Finance, reviewed honestly The Google Finance redesign, explained A Google Finance alternative for classic users A Yahoo Finance alternative for people who miss the old one Google Finance without the AI Why did Google Finance change? Not because users asked The Google Finance portfolio: what changed, and how to keep tracking About Folivue

Folivue is not affiliated with, endorsed by or sponsored by Google LLC, Alphabet Inc., Yahoo, or any exchange or index provider. Market data comes from third parties, may be delayed or inaccurate, and is not investment advice; all other names and marks belong to their owners. Read the full disclaimer.

Market snapshot

Dow Jones0.26%53,417.16+140.16 S&P 5000.28%7,652.86-21.51 Nasdaq0.76%25,980.19-200.26 Russell0.76%2,995.08-22.79 VIX4.76%15.85+0.72

Keep browsing

You may be interested in

TSLATesla, Inc.$348.95
3.83%
AMZNAmazon.com, Inc.$262.07
1.33%
AAPLApple Inc.$310.34
0.32%
AMDAdvanced Micro Devices, Inc.$456.75
3.49%
METAMeta Platforms, Inc.$559.02
1.66%
WTFCWintrust Financial Corporation$151.99
0.45%
PBProsperity Bancshares, Inc.$72.75
0.03%
VLYValley National Bancorp$14.10
0.42%

EDGE: MRBL Enhanced Equity ETF Price, Chart & Stats | Folivue

Home›EDGE • BATS

MRBL Enhanced Equity ETF

$51.580.24%-0.12 Today

After Hours:$51.58(0.00%) +0.00

Closed: Aug 24, 9:30:13 PM UTC-4 · USD · BATS · Disclaimer

$327.801.45%2.79%

RCN Pareto Strategic Allocation ETF$28.40PRTO0.44%Corgi Genomics & Precision Medicine ETF$35.30GNMX1.51%Journey Medical Corporation$7.91DERM2.06%AB Corporate Bond ETF$34.56EYEG0.17%

In the news

StockUS listed securityUS headquartered

Previous close$51.70

Day range$51.58 - 51.58

Year range$41.54 - 51.98

Avg Volume2.82K

P/E ratio25.89

Dividend yield0.00%

Primary exchangeBATS

About

Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposure, the fund will primarily invest in one or more ETFs or options on an ETF or index (each, a “reference asset”). The fund is non-diversified.

Zacks•10 hours ago

Can APLD's Power Advantage Strengthen Its AI Edge Over WULF & CRWV?

The Wall Street Journal•1 hour ago

Oil Edges Higher as Traders Assess U.S. Measures Against Iran